156 related articles for article (PubMed ID: 7113964)
1. Sequential phase II studies of chemotherapy for colorectal cancer with 5-fluorouracil and vindesine with or without methyl-1,3 cis(2 chloroethyl)-1-nitrosourea.
Stroehlein JR; Bedikian AY; Karlin DA; Valdivieso M; Bennetts RW; Bodey GP
Am J Clin Oncol; 1982 Aug; 5(4):421-7. PubMed ID: 7113964
[TBL] [Abstract][Full Text] [Related]
2. Combination chemotherapy containing semustine (MeCCNU) in patients with advanced colorectal cancer previously treated with 5-fluorouracil (5-Fu).
Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A
Am J Clin Oncol; 1983 Apr; 6(2):175-80. PubMed ID: 6829492
[TBL] [Abstract][Full Text] [Related]
3. Combination chemotherapy of colorectal cancer with 5-fluorouracil, methyl-1,3-cis(2-chloroethyl)-1-nitrosourea, and vincristine.
Joss RA; Goldberg RS; Yates JW
Med Pediatr Oncol; 1979; 7(3):251-5. PubMed ID: 542190
[TBL] [Abstract][Full Text] [Related]
4. Randomized phase II studies in advanced colorectal carcinoma: a North Central Cancer Treatment Group study.
Windschitl H; Scott M; Schutt A; McCormack G; Everson L; Cullinan S; Gerstner J; Krook J; Laurie J; Shreck R
Cancer Treat Rep; 1983 Nov; 67(11):1001-8. PubMed ID: 6640551
[TBL] [Abstract][Full Text] [Related]
5. Phase II study of 5-fluorouracil, methyl-CCNU, and daunorubicin in colorectal cancer: a Cancer and Leukemia Group B study.
White LA; Perry MC; Kardinal CG; Kennedy BJ; Weiss RB; Carey RW
Cancer Treat Rep; 1979 Feb; 63(2):215-7. PubMed ID: 445497
[TBL] [Abstract][Full Text] [Related]
6. Chemotherapy of advanced measurable colon and rectal carcinoma with oral 5-fluorouracil, alone or in combination with cyclophosphamide or 6-thioguanine, with intravenous 5-fluorouracil or beta-2'-deoxythioguanosine or with oral 3(4-methyl-cyclohexyl)-1(2-chlorethyl)-1-nitrosourea: a Phase II-III study of the Eastern Cooperative Oncology Group (EST 4273).
Douglass HO; Lavin PT; Woll J; Conroy JF; Carbone P
Cancer; 1978 Dec; 42(6):2538-45. PubMed ID: 365312
[TBL] [Abstract][Full Text] [Related]
7. Metastatic colorectal carcinoma. A prospective randomized trial of Methyl-CCNU, 5-Fluorouracil (5-FU) and vincristine (MOF) versus MOF plus streptozotocin (MOF-Strep).
Kemeny N; Yagoda A; Braun D
Cancer; 1983 Jan; 51(1):20-4. PubMed ID: 6217886
[TBL] [Abstract][Full Text] [Related]
8. Therapy of advanced colorectal cancer with a combination of 5-fluorouracil, methyl-1,3-cis(2-chlorethyl)-1-nitrosourea, and vincristine.
Moertel CG; Schutt AJ; Hahn RG; Reitemeier RJ
J Natl Cancer Inst; 1975 Jan; 54(1):69-71. PubMed ID: 1117460
[TBL] [Abstract][Full Text] [Related]
9. Phase II evaluation of vindesine in the treatment of colorectal and esophageal tumors.
Bedikian AY; Valdivieso M; Bodey GP; Freireich EJ
Cancer Chemother Pharmacol; 1979; 2(4):263-6. PubMed ID: 455586
[TBL] [Abstract][Full Text] [Related]
10. 5-Fluorouracil (5-FU), methyl-CCNU, and vincristine in the treatment of advanced colorectal cancer: phase II study utilizing weekly 5-FU.
Macdonald JS; Kisner DF; Smythe T; Woolley PV; Smith L; Schein PS
Cancer Treat Rep; 1976 Nov; 60(11):1597-600. PubMed ID: 1021233
[TBL] [Abstract][Full Text] [Related]
11. The efficacy of 5-fluorouracil, mitomycin C, and methyl CCNU in advanced colorectal cancer.
Vaughn CB; Chapman J; Garland M; Pederson B; Demitrish MM; Chinn B; Ward D; Enochs K; Groshko G; Rocchio R
Am J Clin Oncol; 1986 Jun; 9(3):196-9. PubMed ID: 3088974
[TBL] [Abstract][Full Text] [Related]
12. Treatment of advanced colorectal cancer with methyl-CCNU plus 5-day 5-fluorouracil infusion.
Kane RC; Cashdollar MR; Bernath AM
Cancer Treat Rep; 1978 Oct; 62(10):1521-5. PubMed ID: 709554
[TBL] [Abstract][Full Text] [Related]
13. Phase I-II study of ftorafur and methyl-CCNU in advanced colorectal cancer.
Belt RJ; Stephens R
Cancer; 1979 Sep; 44(3):869-72. PubMed ID: 383275
[TBL] [Abstract][Full Text] [Related]
14. Combination chemotherapy in patients with advanced colorectal carcinoma previously treated with 5-FU.
Windschitl HE; Krook JE; Everson LK; Cullinan SA; Scott M
Cancer Treat Rep; 1982 Dec; 66(12):2093-4. PubMed ID: 7139652
[No Abstract] [Full Text] [Related]
15. Methyl-CCNU, 6-thioguanine, and 5-fluorouracil in advanced colorectal cancer.
Aroney RS; Dalley DN; Chan WK; Bell DR; Levi JA
Med Pediatr Oncol; 1981; 9(2):181-6. PubMed ID: 7231364
[TBL] [Abstract][Full Text] [Related]
16. A controlled evaluation of recent approaches to biochemical modulation or enhancement of 5-fluorouracil therapy in colorectal carcinoma.
Buroker TR; Moertel CG; Fleming TR; Everson LK; Cullinan SA; Krook JE; Mailliard JA; Marschke RF; Klaassen DJ; Laurie JA
J Clin Oncol; 1985 Dec; 3(12):1624-31. PubMed ID: 2933492
[TBL] [Abstract][Full Text] [Related]
17. Combination chemotherapy of advanced colorectal cancer utilizing 5-fluorouracil, semustine, dacarbazine, vincristine, and hydroxyurea: a phase III trial by the Eastern Cooperative Oncology Group (EST: 4275).
Engstrom PF; MacIntyre JM; Douglass HO; Muggia F; Mittelman A
Cancer; 1982 Apr; 49(8):1555-60. PubMed ID: 7039814
[TBL] [Abstract][Full Text] [Related]
18. Baker's antifol in combination with 5-fluorouracil and methyl-CCNU in the treatment of metastatic colorectal cancer: a Southwest Oncology Group Study (Protocol 7764).
Shaw MT; Bonnet JD; Wilson H; Heilbrun LK
Cancer Treat Rep; 1980; 64(2-3):247-50. PubMed ID: 7407758
[TBL] [Abstract][Full Text] [Related]
19. Combination chemotherapy for advanced colorectal cancer with triazinate, ICRF-159, 5-FU, and methyl-CCNU.
Vogl SE; Qazi R; Berenzweig M
Cancer Treat Rep; 1980; 64(10-11):1143-5. PubMed ID: 7459902
[TBL] [Abstract][Full Text] [Related]
20. Lack of effectiveness of combined 5- fluorouracil and methyl-CCNU therapy in advanced colorectal cancer.
Lokich JJ; Skarin AT; Mayer RJ; Frei E
Cancer; 1977 Dec; 40(6):2792-6. PubMed ID: 589555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]